Advisor Partners II’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $1.24M | Buy |
80,100
+12,802
| +19% | +$198K | 0.05% | 410 |
|
2023
Q2 | $1.06M | Buy |
67,298
+14,696
| +28% | +$231K | 0.05% | 373 |
|
2023
Q1 | $867K | Buy |
52,602
+15,163
| +41% | +$250K | 0.05% | 380 |
|
2022
Q4 | $584K | Buy |
37,439
+8,247
| +28% | +$129K | 0.04% | 478 |
|
2022
Q3 | $379K | Buy |
+29,192
| New | +$379K | 0.03% | 545 |
|